International survey reveals cannabis may benefit endometriosis management, suggesting safety concerns warrant deeper analysis.
There is growing evidence that people with endometriosis are utilising cannabis, whether legally or illicitly procured, for management of pain and associated symptoms. As such, concerns over cannabis use as a medicine are foremost in clinicians' minds, particularly potential adverse effects. This study, a sub‐set of a larger ( n = 889) international survey investigating the self‐reported effectiveness, safety and pharmaceutical de‐prescribing trends of cannabis use in the endometriosis population, showed that 32% experienced side‐effects associated with cannabis use, similar to published literature. However, some of these reported adverse effects have potential clinical utility and may require a more nuanced interpretation.
No takes yet. Share an insight, caveat, or question.
Sinclair et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: